This product includes the webinar and CME/CMLE credit.


Description:

This webinar reviews the updated diagnostic criteria of myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms according to the recently revised WHO Classification, with emphasis on significant changes from the prior (2008) WHO Classification. New and revised entities within this group of diseases will be presented and the appropriate testing required to correctly diagnose these neoplasms will be discussed.


Speaker: Robert P. Hasserjian, MD

Host: Jennifer Dunlap, MD

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: February 15, 2021

Maximum CME/CMLE credit available: 1.0


How to claim credit: To earn CME/CMLE credit, all learners must watch the webinar and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

AMA PRA Category 1 Credit(s)™

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 


You may also be interested in:

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
February 15, 2018
Course Objectives
  • Describe the criteria for establishing a primary diagnosis of myelodysplastic syndrome.
  • Distinguish between the subtypes of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms according to current criteria in the 2016 WHO Classification.
  • Employ ancillary testing (including flow cytometry, immunohistochemistry, cytogenetics, and molecular genetic testing) effectively in the diagnosis, classification, and prognostication of myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
WHO Update 2016: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
Speaker Information
Robert P. Hasserjian MD   [ view bio ]
Individual topic purchase: Selected
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Products
Hasserjian Presentation (+CME)
AMP Regular Member: $5.00
AMP Technologist Member: $5.00
AMP Associate Member: $5.00
Non-member Price: $205.00